Neith Corporation (6236.TWO)
TWD 29.65
(0.0%)
TWD 29.65
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -33.61 Million TWD | -80.64% |
| 2022 | -18.49 Million TWD | -666.63% |
| 2021 | -2.28 Million TWD | 65.3% |
| 2020 | -10.4 Million TWD | 74.4% |
| 2019 | -9.23 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -9.94 Million TWD | 2.06% |
| 2024 Q2 | -2.19 Million TWD | 77.89% |
| 2023 FY | - TWD | -80.64% |
| 2023 Q4 | -10.15 Million TWD | -26.74% |
| 2023 Q3 | -8 Million TWD | -92.25% |
| 2023 Q2 | -4.16 Million TWD | 63.08% |
| 2023 Q1 | -11.28 Million TWD | 5.63% |
| 2022 Q4 | -11.95 Million TWD | 0.0% |
| 2022 FY | - TWD | -666.63% |
| 2021 FY | - TWD | 65.3% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 108.539% |
| Level Biotechnology Inc. | 98.7 Million TWD | 134.051% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 24.875% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 53.394% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -33.199% |
| GlycoNex Incorporation | -126.82 Million TWD | 73.499% |
| VBI | -6.97 Million TWD | -382.071% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 76.61% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 254.104% |
| Visgeneer Inc. | 973 Thousand TWD | 3554.265% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 90.1% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 103.589% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 133.665% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 96.609% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -1834.945% |
| Enimmune corporation | -228.96 Million TWD | 85.321% |
| TaiRx, Inc. | -208.64 Million TWD | 83.891% |
| CHO Pharma, Inc. | -277.73 Million TWD | 87.898% |
| EirGenix Inc. | -664.4 Million TWD | 94.941% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 145.478% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 148.609% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 96.863% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 70.285% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 196.475% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 46.087% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -27.795% |
| RBC Bioscience Corporation | 36.54 Million TWD | 191.964% |
| BiOptic Inc. | 65.03 Million TWD | 151.677% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 95.075% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -1.83% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 38.796% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 107.752% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 27.32% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -89.608% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 67.563% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 58.025% |
| NaviFUS Corp. | -55.79 Million TWD | 39.762% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -102.494% |
| Sinew Pharma Inc. | -163.63 Million TWD | 79.46% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 45.35% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 117.469% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 85.173% |
| AP Biosciences Inc | -325.51 Million TWD | 89.675% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 96.783% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 6.238% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 215.379% |
| Intech Biopharm Corporation | -219.58 Million TWD | 84.694% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 95.015% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 25.23% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 79.106% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 105.127% |
| TCI GENE Inc. | 25.98 Million TWD | 229.364% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 69.622% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 88.157% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 76.975% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 342.671% |
| PharmaEngine, Inc. | 347.3 Million TWD | 109.677% |
| Savior Lifetec Corporation | 219.6 Million TWD | 115.305% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 119.515% |
| OBI Pharma, Inc. | -855.08 Million TWD | 96.069% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 63.69% |
| Acepodia, Inc. | -764.51 Million TWD | 95.604% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 92.695% |